| IPAD-DB ID | C00924 |
| Name | ARE |
| Category | Natural compounds |
| 2D Structure |
|
| 3D Structure | |
| Molecular Formula | C 3 1 H 5 3 N O 2 3 |
| Molecular Weight | 807.7 g/mol |
| IUPAC Name | (2R, 3R, 4S, 5S, 6R)-2-[(2R, 3S, 4R, 5R, 6S)-6-[(1R, 4S, 5S, 6R)-4-[[(2R, 3S, 4S, 5R, 6R)-4, 5-dihydroxy-2-methyl-6-[(2R, 3S, 4R, 5R, 6S)-4, 5, 6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]amino]-5, 6-dihydroxy-2-(hydroxymethyl)cyclohex-2-en-1-yl]oxy-4, 5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3, 4, 5-triol |
| InChI | InChI=1S/C31H53NO23/c1-7-13(16(39)22(45)29(49-7)54-26-11(5-35)50-28(48)21(44)19(26)42)32-9-2-8(3-33)25(18(41)14(9)37)53-31-24(47)20(43)27(12(6-36)52-31)55-30-23(46)17(40)15(38)10(4-34)51-30/h2, 7, 9-48H, 3-6H2, 1H3/t7-, 9+, 10-, 11-, 12-, 13-, 14+, 15-, 16+, 17+, 18-, 19-, 20-, 21-, 22-, 23-, 24-, 25-, 26-, 27-, 28+, 29-, 30-, 31-/m1/s1 |
| InChIKey | JUCZMZWYUIRMPL-NPPSNIQKSA-N |
| Canonical SMILES | CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)O)CO)O)O)NC3C=C(C(C(C3O)O)OC4C(C(C(C(O4)CO)OC5C(C(C(C(O5)CO)O)O)O)O)O)CO |
| PubChem CID | 4369394 |
| DrugBank Accession Number | - |
| CAS Registry Number | - |
| Molecular Weight(Computed by SwissADME) | 807.75 |
| Hac(Computed by SwissADME) | 55 |
| Volume(Computed by ADMETlab 2.0) | 712.485 |
| Density(Computed by ADMETlab 2.0) | 1.133 |
| nRing(Computed by ADMETlab 2.0) | 5 |
| MaxRing(Computed by ADMETlab 2.0) | 6 |
| nHet(Computed by ADMETlab 2.0) | 24 |
| fChar(Computed by ADMETlab 2.0) | 0 |
| nRig(Computed by ADMETlab 2.0) | 30 |
| Flexibility(Computed by ADMETlab 2.0) | 0.4 |
| Stero Centers(Computed by ADMETlab 2.0) | 24 |
| LogS(Computed by ADMETlab 2.0) | 0.749 |
| LogD(Computed by ADMETlab 2.0) | -3.051 |
| logP(Computed by ADMETlab 2.0) | -5.152 |
| TPSA(Computed by SwissADME) | 400.32 |
| Hbond Acceptor(Computed by SwissADME) | 24 |
| Hbond Donor(Computed by SwissADME) | 17 |
| Rotatable Bonds(Computed by SwissADME) |
| GI Absorption(Computed by SwissADME) | Low |
| BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
| P-gp Substrate(Computed by SwissADME) | Yes |
| CYP1A2 Inhibitor(Computed by SwissADME) | No |
| CYP2C19 Inhibitor(Computed by SwissADME) | No |
| CYP2C9 Inhibitor(Computed by SwissADME) | No |
| CYP2D6 Inhibitor(Computed by SwissADME) | No |
| CYP3A4 Inhibitor(Computed by SwissADME) | No |
| log Kp(Skin Permeation)(Computed by SwissADME) | -18.81 |
| Lipinski(Computed by SwissADME) | 3 |
| Ghose(Computed by SwissADME) | 4 |
| Veber(Computed by SwissADME) | 2 |
| Egan(Computed by SwissADME) | 1 |
| Muegge(Computed by SwissADME) | 5 |
| Bioavailability Score(Computed by SwissADME) | 0.17 |